Morbidity and mortality in the surgery arm of EORTC 08941 trial

No abstract is available for this paper.

• Publication year

  2005

• Venue

  European Respiratory Journal

• Publication date

  2005-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1183/09031936.05.00127204PMID 16055865
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prolonged survival in patients with resected non-small cell lung cancer and single-level N2 disease.

  2004cited by this paper
• Morbidity of pneumonectomy in the age of neoadjuvant therapy for lung cancer.

  2004cited by this paper
• Induction chemotherapy (CT) in stage IIIA-N2 non-small cell lung cancer (NSCLC): An analysis of different regimens used in EORTC 08941

  2003cited by this paper
• PL-4 Phase III study of concurrent chemotherapy and full course radiotherapy (CT/RT) versus CT/RT induction followed by surgical resection for stage IIIA(pN2) non-small cell lung cancer (NSCLC): First outcome analysis of North American Intergroup trial 0139 (RTOG 93-09)

  2003cited by this paper
• Postoperative morbidity and mortality after induction chemoradiotherapy for locally advanced lung cancer: an analysis of 350 operated patients.

  2002cited by this paper
• Morbidity and mortality after neoadjuvant therapy for lung cancer: the risks of right pneumonectomy.

  2001cited by this paper
• Preoperative chemotherapy for lung cancer does not increase surgical morbidity.

  2001cited by this paper
• Randomized trial of surgery versus radiotherapy in patients with stage IIIA (N2) non small-cell lung cancer after a response to induction chemotherapy. EORTC 08941.

  2000cited by this paper
• Morbidity and mortality for pulmonary resections in lung cancer after induction treatment

  2000cited by this paper
• Complications from induction regimens for thoracic malignancies. Perioperative considerations.

  1999cited by this paper
• Revisions in the International System for Staging Lung Cancer.

  1997cited by this paper
• Neoadjuvant therapy for lung cancer: a note of caution.

  1993cited by this paper
• Postoperative complications after combined neoadjuvant treatment of lung cancer.

  1993cited by this paper

• Induction chemoimmunotherapy and surgery for unresectable stage III non-small cell lung cancer

  2025cites this paper
• Feasibility and safety of outside the cage subcostal robotic anatomical lung resections: results of a phase I clinical trial

  2025cites this paper
• Surgical consensus for screening, diagnosis, staging, multimodal management and surveillance of early-stage resectable non-small cell lung cancer (NSCLC) in Malaysia

  2025cites this paper
• Operative Challenges After Induction Immunotherapy for Lung Cancer.

  2025cites this paper
• An Updated Review of Management of Resectable Stage III NSCLC in the Era of Neoadjuvant Immunotherapy

  2024cites this paper
• What is the ideal endpoint in early-stage immunotherapy neoadjuvant trials in lung cancer?

  2023cites this paper
• Neoadjuvant therapy in non-small cell lung cancer: basis, promise, and challenges

  2023cites this paper
• Prävention, Diagnostik, Therapie und Nachsorge des Lungenkarzinoms

  2023cites this paper
• Unresectable Stage III NSCLC Should Not be Treated With Neoadjuvant Therapy and Re-Evaluated for Resection.

  2023cites this paper
• Indications de la chirurgie dans les cancers bronchiques non à petites cellules de stades III

  2022cites this paper
• Completion Pneumonectomy for Non-Small-Cell Lung Cancer: Does Induction Treatment Influence Postoperative Outcomes?

  2022cites this paper
• Management of stage IIIA NSCLC: the role of radiotherapy—a narrative review

  2021cites this paper
• Outcomes of surgical resection after neoadjuvant chemoimmunotherapy in locally advanced stage IIIA non-small-cell lung cancer.

  2021cites this paper
• Management of Stage III Non–Small-Cell Lung Cancer: ASCO Guideline

  2021cites this paper
• Major pulmonary resection after neoadjuvant chemotherapy or chemoradiation in potentially resectable stage III non-small cell lung carcinoma

  2021cites this paper
• Lung Cancer Surgery after Treatment with Anti-PD1/PD-L1 Immunotherapy for Non-Small-Cell Lung Cancer: A Case—Cohort Study

  2021cites this paper
• Important Surgical and Clinical End Points in Neoadjuvant Immunotherapy Trials in Resectable NSCLC

  2021cites this paper
• Surgical perspective on neoadjuvant immunotherapy in non-small cell lung cancer.

  2021cites this paper
• Major Pulmonary Resection After Neoadjuvant Therapy in Potentially Resectable Stage IIIA/B Non-Small Cell Lung Carcinoma: R0 or No R0

  2021cites this paper
• Micropapillary pattern of stage IIIA-N2 lung adenocarcinoma is a prognostic factor after adjuvant chemoradiotherapy.

  2020cites this paper
• Pneumonectomy in stage IIIA-N2 non-small cell lung cancer

  2020influential citation
• Heterogeneity of stage IIIA non-small cell lung cancer—different tumours, different nodal status, different treatment, different prognosis: a narrative review

  2020cites this paper
• Cancers bronchiques localement avancés : le rôle du chirurgien

  2020cites this paper
• Adverse events reporting in stage III NSCLC trials investigating surgery and radiotherapy

  2020cites this paper
• Resectable IIIA-N2 Non-Small-Cell Lung Cancer (NSCLC): In Search for the Proper Treatment

  2020cites this paper
• Right-Sided Versus Left-Sided Pneumonectomy After Induction Therapy for Non-Small Cell Lung Cancer.

  2019cites this paper
• Thoracic

  2019cites this paper
• Cancers bronchiques localement avancés: le rôle du chirurgien

  2019cites this paper
• Local treatment of stage IIIA-N2 nonsmall cell lung cancer: surgery and/or radiotherapy.

  2019cites this paper
• Pneumonectomy in Stage IIIA‐N2 NSCLC: Should It Be Considered After Neoadjuvant Chemotherapy?

  2019cites this paper
• Comparing the benefits of chemoradiotherapy and chemotherapy for resectable stage III A/N2 non-small cell lung cancer: a meta-analysis

  2018cites this paper
• The prognostic significance of proliferative indices in surgically resected IIIA-N2 non-small cell lung cancer after induction chemotherapy.

  2017cites this paper
• Advances in the use of surgery and multimodality treatment for N2 non-small cell lung cancer

  2017cites this paper
• Approaches in patients with locally advanced NSCLC : a surgeon's perspective

  2015cites this paper
• Morbidity and mortality after major pulmonary resections in patients with locally advanced stage IIIA non-small cell lung carcinoma who underwent induction therapy.

  2015cites this paper
• Pneumonectomy for lung cancer: contemporary national early morbidity and mortality outcomes.

  2015cites this paper
• The Long-Term Outcomes of Induction Chemoradiotherapy Followed by Surgery for Locally Advanced Non-Small Cell Lung Cancer

  2014cites this paper
• Is sleeve lobectomy comparable in terms of short- and long-term results with pneumonectomy after induction therapy? A multicenter analysis.

  2014cites this paper
• Neoadjuvant chemotherapy is a risk factor for bronchopleural fistula after pneumonectomy for non-small cell lung cancer

  2014cites this paper
• Place de la chirurgie dans le traitement des cancers localement avancés

  2014cites this paper
• Radical treatment of non-small cell lung cancer during the last 5 years.

  2013cites this paper
• Pulmonary resection after chemoradiotherapy for advanced non-small cell lung cancer: the impact of presurgical radiation therapy

  2013cites this paper
• Role of induction therapy: surgical resection of non-small cell lung cancer after induction therapy.

  2013cites this paper
• Advances in surgery of lung cancer

  2012cites this paper
• Pneumonectomy following induction therapy: an evidence-based, experienced-based and eloquence-based point of view.

  2012cites this paper
• An analysis, systematic review, and meta-analysis of the perioperative mortality after neoadjuvant therapy and pneumonectomy for non-small cell lung cancer.

  2012cites this paper
• Results from a single institution phase II trial of concurrent docetaxel/carboplatin/radiotherapy followed by surgical resection and consolidation docetaxel/carboplatin in stage III non-small-cell lung cancer.

  2011cites this paper
• Contemporary Results of Surgical Resection of Non-small Cell Lung Cancer After Induction Therapy: A Review of 549 Consecutive Cases

  2011cites this paper
• VATS Versus Thoracotomy for Major Lung Resection After Induction Therapy

  2011cites this paper
• Current surgical treatment of non-small-cell lung cancer

  2011cites this paper
• Tri-Modality Therapy in Locally Advanced Non-Small-Cell Lung Cancer

  2011cites this paper
• Pneumonectomy is a valuable treatment option after neoadjuvant therapy for stage III non-small-cell lung cancer.

  2010cites this paper
• Pneumonectomies et alternatives techniques

  2010cites this paper
• Surgical management of non-small cell lung cancer with mediastinal lymphadenopathy.

  2010cites this paper
• Pneumectomie e tecniche alternative

  2010cites this paper
• Does induction treatment increase the risk of morbidity and mortality after pneumonectomy? A multicentre case-matched analysis.

  2010cites this paper
• Pneumonectomy for lung cancer after preoperative concurrent chemotherapy and high-dose radiation.

  2010cites this paper
• Surgery after induction chemotherapy in stage IIIA-N2 non-small cell lung cancer: why pneumonectomy should be avoided.

  2010cites this paper
• Soluble epidermal growth factor receptor (sEGFR) and carcinoembryonic antigen (CEA) concentration in patients with non-small cell lung cancer: correlation with survival after erlotinib and gefitinib treatment

  2010cites this paper
• What is the role for surgery in patients with stage III non-small cell lung cancer?

  2009cites this paper
• Results of cutting-edge surgery in stage IIIA-N2 nonsmall cell lung cancer

  2009cites this paper
• ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)

  2009cites this paper
• Impact of neo-adjuvant radiochemotherapy on bronchial tissue viability.

  2009influential citation
• Surgical treatment of stage III non-small cell lung cancer.

  2009cites this paper
• Pneumonectomy after chemoradiation therapy for non-small cell lung cancer: does "side" really matter?

  2009cites this paper
• Does chemotherapy increase morbidity and mortality after pneumonectomy?

  2009cites this paper
• Complications of lung cancer treatment.

  2008cites this paper
• Risks of neoadjuvant chemotherapy and radiation therapy.

  2008cites this paper
• Circulatory support system as a bridge to decision in patients with refractory acute cardiogenic shock: is there a space for extracorporeal membrane oxygenation?

  2008cites this paper
• La place du chirurgien dans l’exploration et le traitement

  2008cites this paper
• Mortality associated with pneumonectomy after induction chemoradiation versus chemotherapy alone in stage IIIA-N2 non-small cell lung cancer.

  2008cites this paper
• What is the optimal treatment of stage IIIA–N2 non-small-cell lung cancer after EORTC 08941?

  2008cites this paper
• Mortality related to neoadjuvant therapy and surgery for stage III non-small-cell lung cancer.

  2008cites this paper
• Early surgical results after pneumonectomy for non-small cell lung cancer are not affected by preoperative radiotherapy and chemotherapy.

  2008cites this paper
• Complications of Lung Cancer Treatment

  2008cites this paper
• Is there a role for surgery in stage IIIA-N2 non-small cell lung cancer?

  2008cites this paper
• Predicting the need for intensive care following lung resection.

  2008cites this paper
• Surgery : therapeutic indications

  2007cites this paper
• Operative risk of pneumonectomy after induction chemoradiotherapy.

  2007cites this paper
• Operative complications and early mortality after induction therapy for lung cancer.

  2007cites this paper
• Role of Induction Chemotherapy in Resectable N2 Non-small Cell Lung Cancer

  2007cites this paper
• Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer.

  2007cites this paper
• Neoadjuvant chemotherapy in the treatment of nonsmall-cell lung cancer

  2007cites this paper
• Induction chemotherapy does not increase the operative risk of pneumonectomy!

  2007cites this paper
• Improved results of induction chemoradiation before surgical intervention for selected patients with stage IIIA-N2 non-small cell lung cancer.

  2007cites this paper
• Operative risk of pneumonectomy after induction chemoradiotherapy.

  2007cites this paper
• Surgery: therapeutic indications.

  2007cites this paper
• Decision Making about Operability in Non-small Cell Lung Cancer

  2007cites this paper
• Difficult Decisions in Thoracic Surgery

  2007cites this paper
• Radiotherapy in non-small-cell lung cancer : changing perspectives in palliative care

  2007cites this paper
• Critères de qualité de la chirurgie d’exérèse des cancers bronchiques non microcellulaires

  2007cites this paper
• Pneumonectomie après chimiothérapie d'induction : attitude téméraire ou démarche raisonnée ?

  2007cites this paper
• Role of preoperative chemotherapy for non-small-cell lung cancer: a meta-analysis.

  2006cites this paper
• The Yield of Mediastinoscopy with Respect to Lymph Node Size, Cell Type, and the Location of the Primary Tumor

  2006cites this paper
• Postoperative complications after induction chemoradiotherapy in patients with non-small-cell lung cancer.

  2006cites this paper
• Update in lung cancer 2005.

  2006cites this paper
• Locally advanced non-small cell lung cancer: role of induction chemotherapy in resectable N2 disease.

  2006cites this paper